AUTHORS: Jansen, Gerrit Dr med et al Anesthesia & Analgesia: September 2021 – Volume 133 – Issue 3 – p 747-754 BACKGROUND: Recently, a very low incidence of 3 per 10,000 and a mortality of 30% were reported for pediatric perioperative cardiac arrest (POCA). However, high-risk patients, namely children already anesthetized on the intensive care unit […]
Read MoreAUTHORS: Patrocínio, Maria D. MD et al Anesthesia & Analgesia: September 2021 – Volume 133 – Issue 3 – p 610-619 BACKGROUND: Residual neuromuscular blockade is associated with an increased incidence of postoperative respiratory complications. The REsidual neuromuscular block Prediction Score (REPS) identifies patients at high risk for residual neuromuscular blockade after surgery. METHODS: A total […]
Read MoreAUTHORS: Boncyk, Christina S. MD et al Anesthesia & Analgesia: September 2021 – Volume 133 – Issue 3 – p 713-722 BACKGROUND: Pharmacologic agents are frequently utilized for management of intensive care unit (ICU) delirium, yet prescribing patterns and impact of medication choices on patient outcomes are poorly described. We sought to describe prescribing practices for […]
Read MoreAUTHORS: Su, Lin MD, PhD et al Anesthesia & Analgesia: September 2021 – Volume 133 – Issue 3 – p 794-810 BACKGROUND: Remifentanil can induce postinfusion cold hyperalgesia. N-methyl-d-aspartate receptor (NMDAR) activation and upregulation of transient receptor potential melastatin 8 (TRPM8) membrane trafficking in dorsal root ganglion (DRG) are critical to cold hyperalgesia derived from neuropathic pain, […]
Read MoreAUTHORS: Zhao, Shiyi MD et al Anesthesia & Analgesia: September 2021 – Volume 133 – Issue 3 – p 781-793 BACKGROUND: Orexin, a neuropeptide derived from the perifornical area of the hypothalamus (PeFLH), promotes the recovery of propofol, isoflurane, and sevoflurane anesthesias, without influencing the induction time. However, whether the orexinergic system also plays a similar […]
Read More